This week has been jam-packed full of 340B activity, but there still doesn’t seem to be a consensus on the program going forward. On Monday, the head of the Health and Human Services Department, Alex Azar, gave his two cents about the program—which largely focused on the need for transparency and oversight over the program.
At a Pew Charitable Trusts event Tuesday, a Texas correctional health specialist spoke about the money his state is saving by using 340B to buy drugs for prisoners. He says Texas saved $90 million last year alone through the program.
By Wednesday, politicians were all warmed-up for a House Energy and Commerce Health subcommittee hearing about the program and how it can be improved. Not only was this the longest 340B hearing I’ve been to, but it was also the most hectic.
Topics of discussion bounced from who should be eligible for the program, what reporting requirements are necessary, the relationships between contracted pharmacies and 340B hospitals, whether hospitals are inappropriately pocketing the savings, and much more. Rep. Buddy Carter (R-Ga.) even brought up a memo stating Botox had been discounted for a movie star in Hollywood.
Sprinkled in between criticism was Democratic pleas to not ax huge shares of the programs’ patient population.
Here are some of the major issues we’re still facing:
Patient definitions: Right now the definition for who falls under the program is nebulous.
Reporting requirements: Hospitals aren’t currently required to report how they’re using the savings from the drug discounts.
Audits: Democrats frequently bring up that it’s mostly hospitals that have gotten audited rather than drug manufacturers. It’s also not clear exactly what an audit of a drug manufacturer entails, one Government Accountability Office representative said at the July 11 hearing.
Contract pharmacies: the amount of pharmacies that partner with 340B hospitals has grown quickly since 2010. That means more patients are getting discounts, but also means there’s more potential to abuse the system.
What’s certain is this isn’t the last time we’ll be hearing debates about the program.
Stay on top of new developments in health law and regulation, and learn more, by signing up for a free trial to Bloomberg Law.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)